Shares of Welltower OP LLC (WELL) surged 5.02% in intraday trading on Tuesday, following a positive analyst update and news of a recent property acquisition. The stock's significant rise outpaced the broader market, reflecting growing investor confidence in the company's prospects.

BNP Paribas Exane, a prominent financial services firm, adjusted its price target for Welltower to $172 from $164, while maintaining an Outperform rating on the stock. This upward revision in the price target suggests that analysts see additional upside potential in Welltower's shares. The new target of $172 represents a substantial premium to the stock's current trading price, potentially fueling investor optimism and contributing to the day's rally.

Adding to the positive sentiment, Welltower Inc. recently announced the registration for resale of 949,412 shares of its common stock. These shares were issued as consideration for the acquisition of certain properties, signaling the company's continued focus on expanding its real estate portfolio. While details of the acquisition were not disclosed, investors may view this as a strategic move to enhance Welltower's market position in the healthcare real estate sector. The combination of analyst optimism and tangible growth initiatives appears to have bolstered investor confidence, driving the stock's impressive intraday performance.